THURSDAY, Nov. 14, 2024 -- Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with...

In a breakthrough study published in Cell Reports, researchers from Professor Idit Shachar’s laboratory at the Weizmann Institute of Science have...

FRIDAY, Nov. 8, 2024 -- Prostate cancer (PCA) treatment is associated with increased rates of complications in the 12 years after treatment, according...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health issues.

Researchers at the Icahn School of Medicine at Mount Sinai, USA, have discovered a way that ovarian cancer tumours manipulate their environment to...

Researchers at the Icahn School of Medicine at Mount Sinai, USA, have discovered a way that ovarian cancer tumours manipulate their environment to...

Fresh from news of a “complete response” from other clinical trials last week, Imugene has now dosed the first patient with a drug combination...

The long-term risks of prostate cancer treatment, including adverse effects and complications, can persist for years. A recent study published in...

Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is hepatocellular carcinoma (HCC),...

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...